Unanimous Thumbs-Up From FDA Advisors for Alzheimer's Drug Advisory committee decision smooths the way for eventual FDA approval Jun 10, 2024
FDA Expands Use of RSV Vaccine to Include More Adults Arexvy now approved for people 50 years and older at increased risk of serious outcomes Jun 10, 2024
'Uncertainty' Is Indeed a Bad Word: A Second Opinion on Pandemic Communication Information should be presented to the public using a three-part approach Jun 09, 2024
Here Are the Top Supreme Court Health Cases to Watch A slew of cases this term could reshape health policy Jun 08, 2024
New Tricuspid Interventions Launched into 'Broken' System Having the technology reach the right patients is a major challenge in the real world Jun 08, 2024
Telomerase Inhibitor Approved for MDS-Related Anemia Imetelstat indicated for lower-risk myelodysplastic syndromes with transfusion-dependent anemia Jun 07, 2024
FDA Reviewers Question Patient Selection for Alzheimer's Drug Candidate Agency's advisors will discuss efficacy, safety of investigational donanemab Jun 06, 2024
Can Mitral Valve Innovators Dig Themselves Out of a Rut? Current transcatheter mitral valve replacement devices a poor match for clinical need Jun 06, 2024
Juul Vaping Products' Stay of Execution Is Now More Official FDA rescinds marketing denials pending further review Jun 06, 2024
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain "Even with some variation, there's still reasonably good protection" Jun 05, 2024
FDA Warns Company Making Stem Cell Products for Pets Safari Stem Cell claims its products can treat a range of animal diseases, FDA says Jun 05, 2024
FDA Panel Votes Against MDMA for PTSD Advisors raised concerns about efficacy, safety, trial design, misconduct Jun 05, 2024
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine The KP.2 subvariant is now dominant in the U.S., FDA staff says in a briefing document Jun 03, 2024
'Uncertainty' Isn't a Bad Word: U.S. Agencies Must Tighten Up H5N1 Communications More effective and efficient public messaging is the need of the hour Jun 03, 2024
FDA Staff Questions Safety of MDMA Treatment for PTSD Advisory committee will weigh benefits and risks next week May 31, 2024
Company Warned Over Atypical Fat-Derived Stem Cell Product Stromal vascular fraction isn't usually sourced from donors May 29, 2024
FDA Urged to Relax Tissue Donation Restrictions for Gay, Bisexual Men Advocates say policy should be based on individualized risk assessments, "not historic bias" May 28, 2024
FDA Advisors Not Convinced Once-Weekly Insulin Is Safe in Type 1 Diabetes Risk of severe hypoglycemia was too much for panel members to overcome May 24, 2024
Blood Test for Colon Cancer Screening Secures FDA Panel's Blessing But advisors urge strong labeling emphasizing Shield test's low sensitivity for advanced adenomas May 24, 2024
House Members Question FDA Officials on Lab-Developed Tests, Missed Deadlines Agency official also seeks Congress's help with preventing device shortages May 22, 2024
Will FDA Advisors Look Past Hypoglycemia Risk With Once-Weekly Insulin? Hypoglycemia was only a concern in patients with type 1 diabetes May 22, 2024
Blood Test for Colon Cancer Screening May Miss Some Precancers, FDA Staff Says Shield could boost screening compliance, but has low sensitivity for advanced adenomas May 22, 2024
FDA Withdraws Approval of FGFR Inhibitor for Bile Duct Cancer Sponsor for infigratinib (Truseltiq) failed to recruit and enroll patients in confirmatory study May 20, 2024
FDA Approves First Interchangeable Biosimilars to Aflibercept for AMD Yesafili and Opuviz can be substituted at a pharmacy without consulting the prescriber May 20, 2024
FDA OKs Novel BiTE Agent for Small Cell Lung Cancer First-in-class tarlatamab achieved a 40% ORR in previously treated extensive-stage SCLC May 16, 2024
FDA Approves New Self-Collection Option for HPV Testing Provides women a way to privately collect their own samples, says maker Roche May 15, 2024
Dark Side of MDMA's Journey to FDA; Fake Studies Shutter Journals; H5N1 Turf Wars This past week in healthcare investigations May 15, 2024
Blockbuster Drug Patent Thickets Signal 'Strategic Behavior' Nearly three-quarters filed after approval, and most claims "peripheral" to active ingredients May 13, 2024
Lost in the Haze: What Would Rescheduling Marijuana Really Do? If you are confused, you're not alone May 13, 2024
Ending Oncology's Toxic Relationship With High Chemotherapy Doses Optimizing doses can improve patient outcomes and lower costs May 10, 2024
Diet Tied to Mortality; FDA's Financial Ties; New Long COVID Trials to Start Health news and commentary gathered by Ƶ staff May 09, 2024
FDA Warns on Insulin Pump Problem Mobile app glitch may cause t:slim X2 insulin pump battery to drain sooner than expected May 08, 2024
FDA Chief on H5N1: 'We Have to Be Ready' Commissioner also detailed plans for "largest reorganization" in agency's history May 08, 2024
What Is Going on With Catheter-Based Pulmonary Embolism Devices in the Real World? Researchers try to make do with the scant data on advanced PE intervention May 04, 2024
Rare Pregnancy Problem Linked to Thiopurines, FDA Says Agency finds risk for intrahepatic cholestasis of pregnancy mostly in IBD, lupus patients May 03, 2024
Narcan May Have Moved Over-the-Counter, but It’s Still Underutilized The potential of this lifesaving medicine will only be achieved if it is truly accessible to all May 01, 2024
FTC Challenges 'Bogus' Patents on Ozempic and Other Drugs Patents block competition and inflate prescription drug cost, says FTC chair May 01, 2024
Why Don't Men Have Their Version of 'The Pill'? A focus on gender equity should include contraceptive equity too Apr 30, 2024
FDA Brings Lab Tests Under Its Oversight Agency will treat lab-developed tests the same as other in vitro diagnostics Apr 29, 2024